# Thanyanan Reungwetwattana – FDA Inspection, Mar 2, 2018

Source: https://www.keypedia.com/records/fda_inspections/thanyanan-reungwetwattana/ec011a38-6e9f-4b1f-b649-22b634d73b13
Source feed: FDA_Inspections

> FDA inspection 1044952 of Thanyanan Reungwetwattana, March 02, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1044952
- Company Name: Thanyanan Reungwetwattana
- Inspection Date: 2018-03-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/rebecca-t-davis/a821f7ef-0c73-4be1-9a9b-3fc2c07f88c1)

Company: https://www.keypedia.com/companies/thanyanan-reungwetwattana/c9ebb48b-6c1f-4133-8d93-619ae7f1c20f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c